Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Mitterhauser

Showing results (171-180 of 207) with videos related to

Pageof 21
Sort By:
Neuro-Oncology|October 11, 2017
Visual and semiquantitative 11C-methionine PET: an independent prognostic factor for survival of newly diagnosed and treatment-naïve gliomasNina Poetsch, Adelheid Woehrer, Johanna Gesperger, et al.
Nuclear Medicine and Biology|November 1, 2018
Molar activity - The keystone in <sup>11</sup>C-radiochemistry: An explorative study using the gas phase methodVerena Pichler, Thomas Zenz, Cécile Philippe, et al.
Neuroimage|July 14, 2012
Normative database of the serotonergic system in healthy subjects using multi-tracer PETMarkus Savli, Andreas Bauer, Markus Mitterhauser, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 8, 2019
Multimodal [<sup>18</sup> F]FDG PET/CT Is a Direct Readout for Inflammatory Bone Repair: A Longitudinal Study in TNFα Transgenic MiceSilvia Hayer, Markus Zeilinger, Volker Weiss, et al.
Frontiers in Oncology|February 23, 2023
Sex-specific radiomic features of L-[S-methyl-<sup>11</sup>C] methionine PET in patients with newly-diagnosed gliomas in relation to IDH1 predictabilityLaszlo Papp, Sazan Rasul, Clemens P Spielvogel, et al.
Translational Psychiatry|October 6, 2019
Correction: Epistasis of HTR1A and BDNF risk genes alters cortical 5-HT1A receptor binding: PET results link genotype to molecular phenotype in depressionAlexander Kautzky, Gregory M James, Cecile Philippe, et al.
Frontiers in Endocrinology|June 28, 2019
<i>In vitro</i> Radiopharmaceutical Evidence for MCHR1 Binding Sites in Murine Brown AdipocytesTheresa Balber, Katarína Benčurová, Florian Wolfgang Kiefer, et al.
The Prostate|October 16, 2019
Response assessment using [<sup>68</sup> Ga]Ga-PSMA ligand PET in patients undergoing systemic therapy for metastatic castration-resistant prostate cancerBernhard Grubmüller, Sazan Rasul, Pascal Baltzer, et al.
JAMA Psychiatry|October 23, 2014
The norepinephrine transporter in attention-deficit/hyperactivity disorder investigated with positron emission tomographyThomas Vanicek, Marie Spies, Christina Rami-Mark, et al.
Frontiers in Physiology|December 12, 2019
Attenuation Correction Approaches for Serotonin Transporter Quantification With PET/MRILucas Rischka, Gregor Gryglewski, Neydher Berroterán-Infante, et al.
Pageof 21

Showing results (171-180 of 207) with videos related to

Sort By:
Pageof 21
Neuro-Oncology|October 11, 2017
Visual and semiquantitative 11C-methionine PET: an independent prognostic factor for survival of newly diagnosed and treatment-naïve gliomasNina Poetsch, Adelheid Woehrer, Johanna Gesperger, et al.
Nuclear Medicine and Biology|November 1, 2018
Molar activity - The keystone in <sup>11</sup>C-radiochemistry: An explorative study using the gas phase methodVerena Pichler, Thomas Zenz, Cécile Philippe, et al.
Neuroimage|July 14, 2012
Normative database of the serotonergic system in healthy subjects using multi-tracer PETMarkus Savli, Andreas Bauer, Markus Mitterhauser, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 8, 2019
Multimodal [<sup>18</sup> F]FDG PET/CT Is a Direct Readout for Inflammatory Bone Repair: A Longitudinal Study in TNFα Transgenic MiceSilvia Hayer, Markus Zeilinger, Volker Weiss, et al.
Frontiers in Oncology|February 23, 2023
Sex-specific radiomic features of L-[S-methyl-<sup>11</sup>C] methionine PET in patients with newly-diagnosed gliomas in relation to IDH1 predictabilityLaszlo Papp, Sazan Rasul, Clemens P Spielvogel, et al.
Translational Psychiatry|October 6, 2019
Correction: Epistasis of HTR1A and BDNF risk genes alters cortical 5-HT1A receptor binding: PET results link genotype to molecular phenotype in depressionAlexander Kautzky, Gregory M James, Cecile Philippe, et al.
Frontiers in Endocrinology|June 28, 2019
<i>In vitro</i> Radiopharmaceutical Evidence for MCHR1 Binding Sites in Murine Brown AdipocytesTheresa Balber, Katarína Benčurová, Florian Wolfgang Kiefer, et al.
The Prostate|October 16, 2019
Response assessment using [<sup>68</sup> Ga]Ga-PSMA ligand PET in patients undergoing systemic therapy for metastatic castration-resistant prostate cancerBernhard Grubmüller, Sazan Rasul, Pascal Baltzer, et al.
JAMA Psychiatry|October 23, 2014
The norepinephrine transporter in attention-deficit/hyperactivity disorder investigated with positron emission tomographyThomas Vanicek, Marie Spies, Christina Rami-Mark, et al.
Frontiers in Physiology|December 12, 2019
Attenuation Correction Approaches for Serotonin Transporter Quantification With PET/MRILucas Rischka, Gregor Gryglewski, Neydher Berroterán-Infante, et al.
Pageof 21